Literature DB >> 32302939

Comparison of acidity and metal ion affinity of D-Glucosamine and N-acetyl-D-glucosamine, a DFT study.

Zahrabatoul Mosapour Kotena1, Alireza Fattahi2.   

Abstract

The derivatives of glucose such as glucosamine (β-D-GlcN) and N-acetyl-D-β-glucosamine (GlcNAc) are significant in several biological systems. D-GlcN has been used widely to treat osteoarthritis in humans and animal models as well as GlcNAc has been proposed as a treatment for autoimmune diseases. The DFT/B3LYP/6-311++G (d,p) method as well as QTAIM and NBO analyses were used to the acidity values of D-GlcN and GlcNAc sugars and their complexes with alkali ions in the gas phase. The Li+, Na+ and K+ prefer bi-dentate chelate in these complexes. The computed results indicate that metal ion affinity (MIA) in GlcNAc is higher than that in D-GlcN. There are direct correlations between the MIA values of D-GlcN and GlcNAc sugars and the atomic numbers of Li, Na, and K. The calculated acidity values for GlcNAc at C2-NH and C6-HO6 sites are 331 and 333 kcal mol-1, respectively. Whereas the calculated acidity values for D-GlcN at C2-NH and C6-HO6 sites are 365 and 372 kcal mol-1, respectively. The AIM and NBO analyses indicate the presence of intramolecular H-bonds in GlcNAc sugar in both its neutral form and conjugate base; whereas D-GlcN indicates intramolecular H-bonds in only its conjugate base.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AIM; Acidity; DFT; Glucosamine; H-bond; MIA; Metal cations; N-Acetyl-d-glucosamine

Mesh:

Substances:

Year:  2020        PMID: 32302939     DOI: 10.1016/j.jmgm.2020.107612

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  1 in total

1.  Evaluation of hydrogen bonds formation in the selected rare sugars based on 6-31G* and 6-311 +  + G(d,p) basis sets.

Authors:  Zahrabatoul Mosapour Kotena; Mozhan Razi; Sara Ahmadi
Journal:  J Mol Model       Date:  2021-10-09       Impact factor: 1.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.